Clinical Trial Update: Long-term Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment (Planetarium Study) [Phase 2, Phase 3]

View source ↗

Summary

The Planetarium Study, a Phase 2/3 trial, reports completed results on using rabeprazole to prevent recurrence of aspirin-induced gastric and duodenal ulcers, w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Gastric Ulcer

Drugs mentioned

• Rabeprazole (rabeprazole)

Snippet

Sponsor: Eisai Co., Ltd. | Conditions: Gastric Ulcers Duodenal Ulcers Caused by Low-dose Aspirin | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2015-11-16